These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25488141)

  • 21. What is needed for phage therapy to become a reality in Western medicine?
    Brüssow H
    Virology; 2012 Dec; 434(2):138-42. PubMed ID: 23059181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Programming Bacteriophages by Swapping Their Specificity Determinants.
    Goren MG; Yosef I; Qimron U
    Trends Microbiol; 2015 Dec; 23(12):744-746. PubMed ID: 26526502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage biocontrol for reducing bacterial foodborne pathogens in produce and other foods.
    Vikram A; Callahan MT; Woolston JW; Sharma M; Sulakvelidze A
    Curr Opin Biotechnol; 2022 Dec; 78():102805. PubMed ID: 36162186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage biocontrol in animals and meat products.
    Atterbury RJ
    Microb Biotechnol; 2009 Nov; 2(6):601-12. PubMed ID: 21255295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N
    Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protection against bacteriophage contamination in industrial fermentation processes--investigation and applications of phage resistance mechanisms in bacteria].
    Ogata S; Eguchi T; Doi K
    Uirusu; 2000 Jun; 50(1):17-26. PubMed ID: 10998975
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriophages BCP1-1 and BCP8-2 require divalent cations for efficient control of Bacillus cereus in fermented foods.
    Bandara N; Jo J; Ryu S; Kim KP
    Food Microbiol; 2012 Aug; 31(1):9-16. PubMed ID: 22475937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New dawn for phage therapy.
    Dixon B
    Lancet Infect Dis; 2004 Mar; 4(3):186. PubMed ID: 14998510
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical aspects of phage therapy.
    Międzybrodzki R; Borysowski J; Weber-Dąbrowska B; Fortuna W; Letkiewicz S; Szufnarowski K; Pawełczyk Z; Rogóż P; Kłak M; Wojtasik E; Górski A
    Adv Virus Res; 2012; 83():73-121. PubMed ID: 22748809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational models of populations of bacteria and lytic phage.
    Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
    Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal bacteriophage mutation rates for phage therapy.
    Kysela DT; Turner PE
    J Theor Biol; 2007 Dec; 249(3):411-21. PubMed ID: 17904162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting gut bacteriophages for human health.
    Dalmasso M; Hill C; Ross RP
    Trends Microbiol; 2014 Jul; 22(7):399-405. PubMed ID: 24656964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The challenge of controlling foodborne diseases: bacteriophages as a new biotechnological tool].
    Jorquera D; Galarce N; Borie C
    Rev Chilena Infectol; 2015 Dec; 32(6):678-88. PubMed ID: 26928505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriophages and their application in food safety.
    García P; Martínez B; Obeso JM; Rodríguez A
    Lett Appl Microbiol; 2008 Dec; 47(6):479-85. PubMed ID: 19120914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-harvest application of lytic bacteriophages for biocontrol of foodborne pathogens and spoilage bacteria.
    Hertwig S; Hammerl JA; Appel B; Alter T
    Berl Munch Tierarztl Wochenschr; 2013; 126(9-10):357-69. PubMed ID: 24199377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respirable bacteriophages for the treatment of bacterial lung infections.
    Hoe S; Semler DD; Goudie AD; Lynch KH; Matinkhoo S; Finlay WH; Dennis JJ; Vehring R
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):317-35. PubMed ID: 23597003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hurdles in bacteriophage therapy: deconstructing the parameters.
    Tsonos J; Vandenheuvel D; Briers Y; De Greve H; Hernalsteens JP; Lavigne R
    Vet Microbiol; 2014 Jul; 171(3-4):460-9. PubMed ID: 24315040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
    Hesse S; Adhya S
    Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.